SCHEMBL13428461

SCHEMBL13428461

CC[C@@H](N)CN(C)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.52
PRMT6 Q96LA8 1/20 0.52
PRMT8 Q9NR22 1/20 0.52
AOC3 Q16853 1/20 0.48
ALDH1A1 P00352 3/20 0.47
TSHR P16473 3/20 0.47
LMNA P02545 2/20 0.46
USP2 O75604 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
PYCR1 P32322 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
BLM P54132 1/20 0.44
DNM1 Q05193 1/20 0.44
SIGMAR1 Q99720 1/20 0.43
KDM4E B2RXH2 1/20 0.43
EPHX1 P07099 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21910026 1.00 CARM1 (0.52) CARM1PRMT6PRMT8AOC3ALDH1A1
SCHEMBL11116432 0.85 EPHX1 (0.57) CARM1PRMT6PRMT8AOC3ALDH1A1
SCHEMBL14085930 0.83 CNR2 (0.46) CARM1PRMT6PRMT8AOC3ALDH1A1
SCHEMBL13428442 0.82 SIGMAR1 (0.49) CARM1PRMT6PRMT8AOC3ALDH1A1
SCHEMBL18732997 0.82 CARM1 (0.58) CARM1PRMT6PRMT8AOC3ALDH1A1
SCHEMBL16209876 0.81 CARM1 (0.55) CARM1PRMT6PRMT8AOC3ALDH1A1
SCHEMBL1006191 0.81 CARM1 (0.55) CARM1PRMT6PRMT8AOC3ALDH1A1
SCHEMBL3211466 0.81 CARM1 (0.55) CARM1PRMT6PRMT8AOC3ALDH1A1
SCHEMBL18890757 0.79 CARM1 (0.48) CARM1PRMT6PRMT8AOC3ALDH1A1
SCHEMBL25072138 0.78 CARM1 (0.45) CARM1PRMT6PRMT8AOC3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS HDAC1, HDAC11, HDAC2 CARM1 14/4885PRMT6 425/4885PRMT8 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.